Weight loss

Ynetnews Channels

More Channels

Weather
Homepage
Shopping

More sites

Contact

20°

Weather

Ynet Channels

More Channels

More Sites

Contact

Weight loss

Breakthrough in nephrology: Ozempic slows kidney disease progression by 24%

Ozempic, known for weight loss and diabetes care, now EU-approved to cut kidney disease risk in type 2 diabetes; studies show it slows kidney disease by 24%, reduces mortality by 20% and lowers heart attack and stroke risks

Tzur Gueta | 12.16.24

Sad? Go for a run: This is how running will make you happier

Can running replace therapy? Running is more than fitness as it improves our self image, boosts positive hormones, and is even a substitute for meditation

Yogev Israeli | 12.10.24

זריקת הרזיה וויגובי, מונג'רו, אלי לילי, נובו נורדסיק

New drug leads the weight loss injection market

Report shows Eli Lilly's Mounjaro outpaces Wegovy in weight-loss trial, as participants lost an average of 20% body weight with Mounjaro over 72 weeks, compared to 13.7% with Wegovy

Tzur Gueta | 12.05.24

Israel approves Rezin weight loss pill for indefinite use

Health Ministry lifts a 3-month limit previously imposed following a series of successful studies; 'The most important factor in our decision was the well-being of the patients' says Dr. Rakefet Bachrach

Tzur Gueta | 11.26.24

Counterfeit diabetes, weight-loss drugs raise alarm after series of fatalities

Reports indicate 10 deaths and over 100 hospitalizations may be linked to counterfeit semaglutide, found in knockoffs of weight-loss drugs like Ozempic; manufacturer warns unregulated versions, not FDA-approved, could endanger public health

Tzur Gueta | 11.09.24

Israeli weight loss pill makes history with FDA approval

The Israeli Epitomee pharmaceutical company receives FDA approval for new weight loss pill which expands in the stomach and does not contain an active agent; Will the Israeli pill sway the market?

Dr. Lior Neuman | 09.26.24

A new weight loss injection is coming to Israel

Eli Lilly announces it's new Mounjaro injection will be avaliable in the country from September 15, but how effective is it and how does it compare to Ozempic?

Ron Crissy | 09.12.24

How to avoid common mistakes when attempting to lose weight

A clinical dietitian explains why it’s so hard for us to stick to a weight-loss plan—and how we can overcome it, maybe even with surprising ease

Ziv Zafrani | 08.25.24

נשיא רוסיה פוטין ו רודן צפון קוריאה קים ג'ונג און ב פסגה ב פיונגיאנג

North Korea seeks new drugs to treat Kim Jong Un's obesity

North Korean leader estimated to weigh over 308 pounds, putting him at high risk of conditions like heart disease, high blood pressure and diabetes, which he has reportedly experienced since his early 30s

Ynetnews | 08.02.24

Yogurt makers see US sales rise, driven by weight-loss drugs revolution

Ozempic revolution negatively impacts market value of food and drink companies while creating opportunities for those offering low-sugar, high-protein and nutrient-rich products

Ynetnews | 06.27.24

Clothing retailers say weight-loss drugs created unprecedented demand for smaller sizes in US

Retailers, like Rent the Runway, Amarra and Lafayette 148, experiencing unprecedented demand for smaller sizes, with customers experimenting with new, more body-hugging and risqué styles after weight loss

Ynetnews | 06.18.24

As analysts forecast weight-loss drug market boom, counterfeits becoming real-world problem

Patients resorting to obtaining discounted medications from unknown sources, posing risks of counterfeit or substandard drugs

Ynetnews | 06.05.24

Ozempic found to reduce kidney disease risk and death in diabetes patients

Novo Nordisk and rival Eli Lilly aim to expand insurance coverage of their weight-loss drugs, including Ozempic, by demonstrating additional medical benefits

Ynetnews | 05.28.24

Strength or aerobics training: which is better for weight loss?

Weight loss can be a challenging goal to achieve and should always involve exercise, but what are the actual benefits? Tel Aviv University’s Professor Yftach Gepner explains

Eitan Gefen | 05.02.24

Ozempic will no longer be prescribed for weight loss, Health Ministry orders

Now that the drug Wegovy has been introduced for treating obesity, Ozempic should only be prescribed for the treatment of diabetes; Neither drug is covered for treating obesity, however, and Wegovy is 2-3 times more expensive

Adir Yanko | 04.12.24